Trump Administration Implements "Most Favored Nations" Drug Pricing Reform

Strategic Insights -

President Donald Trump declared that the U.S. would no longer tolerate "profiteering and price gouging from Big Pharma" as he signed an executive order implementing the "most favored nations" drug pricing policy. The policy sets a price ceiling for prescription drugs in the U.S. based on the lowest price paid in other developed countries. Trump claimed that some prescription drug prices would be reduced by 50 to 80 to 90% immediately. The order also aims to limit the subsidies provided to foreign countries and to allow American patients to buy drugs directly from manufacturers at a lower price.

Key Takeaways:

  • The executive order directs the U.S. Trade Representative and Secretary of Commerce to take action against foreign countries that engage in unfair trade practices that drive up prices in the U.S.
  • The order instructs the Administration to communicate price targets to pharmaceutical manufacturers to ensure that the U.S. gets the best deal.
  • The Secretary of Health and Human Services will establish a mechanism through which American patients can buy their drugs directly from manufacturers who sell at a "Most-Favored-Nation" price.
  • If drug manufacturers fail to offer most-favored-nation pricing, the Order directs the Secretary of Health and Human Services to impose rules that require most-favored-nation pricing and to take other aggressive measures to reduce drug prices.
  • Health and Human Services Secretary Robert F. Kennedy Jr. praised the policy, stating that it had the potential to make a significant difference in the lives of American patients.
  • The Pharmaceutical Research and Manufacturers of America trade group opposes the order, claiming that it will cut billions of dollars from Medicare and jeopardize hundreds of billions of dollars in investments in the U.S.

Statistics:

  • The U.S. accounts for only 4% of the world's population but pharmaceutical companies make more than two-thirds of their profits in America.
  • The transition to the new pricing system is expected to reduce prices for some prescription drugs by 50 to 80 to 90%.
  • The order aims to limit the subsidies provided to foreign countries, which currently pay a small fraction of the price of prescription drugs compared to the U.S.

Sources:

  • "President Trump Sings Executive Order Implementing Most Favored Nations Drug Pricing," White House (no date specified)
  • "Trump Administration Takes Aim at 'Price Gouging' in New Executive Order," Fox News (no date specified)
  • "Remarks of President Trump on Most Favored Nations for Drug Pricing," White House (no date specified)